Engineering Portal
Blog
Contact Us
Technology
Technology
Genome Editing
History of CRISPR
How does CRISPR work?
Digital Genome Engineering
The MAD7™ Nuclease
Biosecurity
Products
Products
Onyx Instrument
Onyx Kits
Onyx Assays
Iterative Editing
Engineering Portal
Applications
Applications
Genome Discovery
Genome Discovery
Salt Stress
Adaptive Laboratory Evolution
Essential Gene Discovery
Forward Engineering
Forward Engineering
BMI Tolerance
Lysine Metabolic Engineering
Protein Engineering
Protein Production
Iterative Strain Improvement
Stress Tolerance
Resources & Support
Resources & Support
Videos & Webinars
Technical Documents
Safety Data Sheets
FAQ
Contact Us
About Us
About Us
Careers
Leadership
Job Listings
News & Events
Engineering Portal
Blog
Contact Us
The Inscripta
®
Blog
Subscribe
Genome-scale engineering
Digital genome engineering
Target discovery
Pathway engineering
Heterologus models
Biosecurity
Bioeconomy
Employee Spotlight
MAD7
Iterative Genome Engineering
February 8, 2022
"Digital Genome Engineering: Unlocking the Potential of Synthetic Biology" Symposium Highlights
Inscripta partnered with Build With Biology to put on a half-day virtual symposium “Digital Genome Engineering: Unlocking the Potential of…
Read More
February 1, 2022
Inside Inscripta: Steven Alvarez, Systems Integration
We continue to introduce Scripters who recently joined the company and today’s guest is Steven Alvarez, Scientist on the Systems Integration…
Read More
January 25, 2022
JP Morgan 2022: The Promise of Synthetic Biology
The healthcare industry kicks off each new year not when the ball drops in Times Square but with the start of the annual JP Morgan Healthcare…
Read More
January 18, 2022
Ginkgo Bioworks Incorporates the Onyx® platform into its foundries
Ginkgo Bioworks, the leading horizontal platform for cell programming, has recently adopted the Onyx platform into its foundries. The company…
Read More
January 11, 2022
What Makes CRISPR Like a Movie Star? SynBioBeta podcast with Nandini Krishnamurthy
Nandini Krishnamurthy, Inscripta’s VP of Microbial Business, appeared as a guest on SynBioBeta’s Built with Biology podcast. The new podcast…
Read More
January 4, 2022
Inside Inscripta: Gözde Gencer, System Integration
What’s one of the most important elements for introducing a game-changing technology like our Onyx® Genome Engineering Platform? A team of…
Read More
December 21, 2021
Inscripta’s MAD7™ CRISPR Nucleases Helping Hudson River Biosciences Improve Plant Editing
In a recent webinar, Ben Mijts of Inscripta, and Gabino Sanchez of Hudson River Biotechnology, demonstrate how Inscripta’s MADzyme™ family of…
Read More
December 14, 2021
New Market Report Finds Near-Boundless Opportunity in Synthetic Biology
A new U.S. thematic market report from Barclays’ Equity Research team shines a spotlight on the tremendous potential in the Synthetic Biology…
Read More
December 7, 2021
Inside Inscripta: Reem Baraka, Sequencing
While Inscripta is a genome engineering company, we also make heavy use of DNA sequencing — so much that we have a high-capacity internal…
Read More
2 of 9